Axis MF’s Shreyash Devalkar suggests largecaps are fairly priced, while mid and smallcaps, despite growth potential, need further valuation correction. He notes earning downgrades are following stock price falls, with FY26 downgrades largely priced in. Devalkar favors financial services and pharmaceuticals, reducing exposure to export-oriented and industrial names, emphasizing a stock-picker market driven by risk-reward frameworks.
Mala Gaonkar’s hedge fund assets hit $6 billion in three years
Mala Gaonkar’s SurgoCap Partners experienced a rapid ascent, tripling its assets to $6 billion within three years of its 2023 launch. This marked one of
January 24, 2026